Big Data and Biofluids: Elizabeth O'Day's precision approach to Biology

Big Data and Biofluids: Elizabeth O'Day's precision approach to Biology

Elizabeth O'Day Elizabeth O'Day

13 Dec '18

401

Imagine a society where medicine can be personalized and patients can help one another with their very own biomarkers. That's a world that Dr. Elizabeth O'Day, Founder and CEO, Olaris Therapeutics, is trying to establish.

Comments

There are no comments yet. Be the first to post a comment.

For better web experience, please use the website in portrait mode